ABL-BCR expression does not correlate with deletions on the derivative chromosome 9 or survival in chronic myeloid leukemia.
de la Fuente
J
J
Merx
K
K
Steer
E J
EJ
Müller
M
M
Szydlo
R M
RM
Maywald
O
O
Berger
U
U
Hehlmann
R
R
Goldman
J M
JM
Cross
N C
NC
Melo
J V
JV
Hochhaus
A
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001483:Base Sequence; D002648:Child; D002899:Chromosomes, Human, Pair 9 / Q000235:genetics*; D005260:Female; D016044:Fusion Proteins, bcr-abl; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000453:epidemiology / Q000235:genetics* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D015514:Oncogene Proteins, Fusion / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D017384:Sequence Deletion; D015996:Survival Rate
D015514:Oncogene Proteins, Fusion; C406060:abl-bcr fusion protein, human; D016044:Fusion Proteins, bcr-abl